
    
      Primary endpoint: 18 months OS, Secondary endpoints: Overall Survival(OS), 12 months survival
      rate(12mo OS), 24 months survival rate(24mo OS), Progression-Free Survival(PFS), Time to
      treatment failure (TTF), Objective Response Rate(ORR), Disease Control Rate(DCR), Duration of
      Response(DOR) ,Safety and EuroQol 5-Dimension 5-Level (EQ-5D-5L) Questionnaire
    
  